Physicians

Residents

Session: ECONTOUR: Lung Econtouring: Navigating the Ever-Growing Complexity of Lung Treatment Planning

Targeting the Primary Tumor and Regional Nodes For Patients with NSCLC and Limited Metastatic Sites

Thursday, March 10, 2022

1:05 PM – 2:05 PM US EST

Speaker(s)

Bradford A. Perez, MD

Department of Radiation Oncology
H. Lee Moffitt Cancer Center
Tampa, Florida, United States

Disclosure: AstraZeneca (Individual(s) Involved: Self): Consultant/Advisory Board; Bristol-Myers Squibb (Individual(s) Involved: Self): Consultant/Advisory Board, Research Grant; G1 Therapeutics (Individual(s) Involved: Self): Consultant/Advisory Board

PDF Slides

Participants should be aware of the following financial/non-financial relationships:

Bradford A. Perez, MD: AstraZeneca (Individual(s) Involved: Self): Consultant/Advisory Board; Bristol-Myers Squibb (Individual(s) Involved: Self): Consultant/Advisory Board, Research Grant; G1 Therapeutics (Individual(s) Involved: Self): Consultant/Advisory Board

Learning Objectives:

Identify patients with Stage IV NSCLC who may benefit from consolidative thoracic radiotherapy
Design thoracic radiation treatment contours for a patient with oligometastatic lung cancer
Understand radiation dose-volume constraint considerations with moderately hypofractioned (~8-15fx) thoracic radiotherapy